AICAR Enhances the Phagocytic Ability of Macrophages towards Apoptotic Cells through P38 Mitogen Activated Protein Kinase Activation Independent of AMP-Activated Protein Kinase.
Recent studies have suggested that 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) increases macrophage phagocytosis through adenosine monophosphate-activated protein kinase (AMPK). However, little information is available on the effects of AICAR on the clearance of apoptotic cells by ma...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC4447456?pdf=render |
| _version_ | 1811230171033763840 |
|---|---|
| author | Hui Quan Joung-Min Kim Hyun-Jung Lee Seong-Heon Lee Jeong-Il Choi Hong-Beom Bae |
| author_facet | Hui Quan Joung-Min Kim Hyun-Jung Lee Seong-Heon Lee Jeong-Il Choi Hong-Beom Bae |
| author_sort | Hui Quan |
| collection | DOAJ |
| description | Recent studies have suggested that 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) increases macrophage phagocytosis through adenosine monophosphate-activated protein kinase (AMPK). However, little information is available on the effects of AICAR on the clearance of apoptotic cells by macrophages, known as efferocytosis, which is essential in maintaining tissue homeostasis and resolving inflammation. AICAR increased p38 MAPK activation and the phagocytosis of apoptotic cells by macrophages, which were inhibited by the p38 MAPK inhibitor, SB203580, the TGF-beta-activated kinase 1 (TAK1) inhibitor, (5Z)-7-oxozeaenol, and siRNA-mediated knock-down of p38α. AICAR increased phosphorylation of Akt, but the inhibition of PI3K/Akt activity using LY294002 did not affect the AICAR-induced changes in efferocytosis in macrophages. CGS15943, a non-selective adenosine receptor antagonist, did not affect AICAR-induced changes in efferocytosis, but dipyridamole, an adenosine transporter inhibitor, diminished the AICAR-mediated increases in efferocytosis. AICAR-induced p38 MAPK phosphorylation was not inhibited by the AMPK inhibitor, compound C, or siRNA-mediated knock-down of AMPKα1. Inhibition of AMPK using compound C or 5'-iodotubercidin did not completely block AICAR-mediated increases in efferocytosis. Furthermore, AICAR also increased the removal of apoptotic neutrophils or thymocytes in mouse lungs. These results reveal a novel mechanism by which AICAR increases macrophage-mediated phagocytosis of apoptotic cells and suggest that AICAR may be used to treat efferocytosis-related inflammatory conditions. |
| first_indexed | 2024-04-12T10:25:47Z |
| format | Article |
| id | doaj.art-2881579537bd415ea6a147715206bca2 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-04-12T10:25:47Z |
| publishDate | 2015-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-2881579537bd415ea6a147715206bca22022-12-22T03:36:59ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01105e012788510.1371/journal.pone.0127885AICAR Enhances the Phagocytic Ability of Macrophages towards Apoptotic Cells through P38 Mitogen Activated Protein Kinase Activation Independent of AMP-Activated Protein Kinase.Hui QuanJoung-Min KimHyun-Jung LeeSeong-Heon LeeJeong-Il ChoiHong-Beom BaeRecent studies have suggested that 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) increases macrophage phagocytosis through adenosine monophosphate-activated protein kinase (AMPK). However, little information is available on the effects of AICAR on the clearance of apoptotic cells by macrophages, known as efferocytosis, which is essential in maintaining tissue homeostasis and resolving inflammation. AICAR increased p38 MAPK activation and the phagocytosis of apoptotic cells by macrophages, which were inhibited by the p38 MAPK inhibitor, SB203580, the TGF-beta-activated kinase 1 (TAK1) inhibitor, (5Z)-7-oxozeaenol, and siRNA-mediated knock-down of p38α. AICAR increased phosphorylation of Akt, but the inhibition of PI3K/Akt activity using LY294002 did not affect the AICAR-induced changes in efferocytosis in macrophages. CGS15943, a non-selective adenosine receptor antagonist, did not affect AICAR-induced changes in efferocytosis, but dipyridamole, an adenosine transporter inhibitor, diminished the AICAR-mediated increases in efferocytosis. AICAR-induced p38 MAPK phosphorylation was not inhibited by the AMPK inhibitor, compound C, or siRNA-mediated knock-down of AMPKα1. Inhibition of AMPK using compound C or 5'-iodotubercidin did not completely block AICAR-mediated increases in efferocytosis. Furthermore, AICAR also increased the removal of apoptotic neutrophils or thymocytes in mouse lungs. These results reveal a novel mechanism by which AICAR increases macrophage-mediated phagocytosis of apoptotic cells and suggest that AICAR may be used to treat efferocytosis-related inflammatory conditions.http://europepmc.org/articles/PMC4447456?pdf=render |
| spellingShingle | Hui Quan Joung-Min Kim Hyun-Jung Lee Seong-Heon Lee Jeong-Il Choi Hong-Beom Bae AICAR Enhances the Phagocytic Ability of Macrophages towards Apoptotic Cells through P38 Mitogen Activated Protein Kinase Activation Independent of AMP-Activated Protein Kinase. PLoS ONE |
| title | AICAR Enhances the Phagocytic Ability of Macrophages towards Apoptotic Cells through P38 Mitogen Activated Protein Kinase Activation Independent of AMP-Activated Protein Kinase. |
| title_full | AICAR Enhances the Phagocytic Ability of Macrophages towards Apoptotic Cells through P38 Mitogen Activated Protein Kinase Activation Independent of AMP-Activated Protein Kinase. |
| title_fullStr | AICAR Enhances the Phagocytic Ability of Macrophages towards Apoptotic Cells through P38 Mitogen Activated Protein Kinase Activation Independent of AMP-Activated Protein Kinase. |
| title_full_unstemmed | AICAR Enhances the Phagocytic Ability of Macrophages towards Apoptotic Cells through P38 Mitogen Activated Protein Kinase Activation Independent of AMP-Activated Protein Kinase. |
| title_short | AICAR Enhances the Phagocytic Ability of Macrophages towards Apoptotic Cells through P38 Mitogen Activated Protein Kinase Activation Independent of AMP-Activated Protein Kinase. |
| title_sort | aicar enhances the phagocytic ability of macrophages towards apoptotic cells through p38 mitogen activated protein kinase activation independent of amp activated protein kinase |
| url | http://europepmc.org/articles/PMC4447456?pdf=render |
| work_keys_str_mv | AT huiquan aicarenhancesthephagocyticabilityofmacrophagestowardsapoptoticcellsthroughp38mitogenactivatedproteinkinaseactivationindependentofampactivatedproteinkinase AT joungminkim aicarenhancesthephagocyticabilityofmacrophagestowardsapoptoticcellsthroughp38mitogenactivatedproteinkinaseactivationindependentofampactivatedproteinkinase AT hyunjunglee aicarenhancesthephagocyticabilityofmacrophagestowardsapoptoticcellsthroughp38mitogenactivatedproteinkinaseactivationindependentofampactivatedproteinkinase AT seongheonlee aicarenhancesthephagocyticabilityofmacrophagestowardsapoptoticcellsthroughp38mitogenactivatedproteinkinaseactivationindependentofampactivatedproteinkinase AT jeongilchoi aicarenhancesthephagocyticabilityofmacrophagestowardsapoptoticcellsthroughp38mitogenactivatedproteinkinaseactivationindependentofampactivatedproteinkinase AT hongbeombae aicarenhancesthephagocyticabilityofmacrophagestowardsapoptoticcellsthroughp38mitogenactivatedproteinkinaseactivationindependentofampactivatedproteinkinase |